Close
Achema middle east
swop processing & packaging

Drug Research

EU May Lose Edge Due To Proposed Law, Says Pharma Lobby

In a major concern surrounding Europe’s pharma industry, there is an anticipation that it could go on to lose out to elevated competition from emerging...

SK pharmteco Doubles Viral Vector Production Capacity in Europe

SK pharmteco, SK Inc.'s contract development manufacturing organization (CDMO) for pharmaceuticals, completed its second facility for cell and gen e therapies (CGT) manufacturing in Europe. With...

Croda announces two new partnerships to drive sustainable delivery systems for the pharmaceutical industry

Croda International Plc (Croda) announced that it has signed two new partnership agreements that will help the pharmaceutical industry move towards a more sustainable supply...

Sygnature Discovery launches its LPS in vivo model to profile early – stage anti-inflammatory drugs

Sygnature Discovery has established an in vivo LPS model of inflammation which can help understand life-limiting neuroinflammatory conditions like Parkinson’s disease, multiple sclerosis, Alzheimer’s disease,...

Innovate UK – funded biotech company accelerates cheaper drug and vaccine manufacture after biocomputer breakthrough

An Innovate UK-backed biotech company has achieved a pioneering biocomputer breakthrough which is accelerating the development and manufacture of cheaper drugs and vaccines. BiologIC Technologies, inventor...

Rising Demand Fuels Asia Pacific Pharmaceutical CDMO Market

The Asia Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market is expected to see significant growth. Factors driving this include rising pharmaceutical demand, increased...

Rising Demand Drive Small Molecule Innovator CDMO Market

According to insights, the market for contract development and manufacturing organizations (CDMOs) specializing in small molecule innovation is estimated to reach a value of $48.09...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »